true
Icon to close the modal
Support
Sales
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Modal Close Icon
Contact sales

For sales inquiries, technical support and customer support complete the following form:

Capability:

Select subject
Anesthesia delivery
Biopsy
Biosciences
Biosurgery
Cervical cancer screening
Drug delivery systems
Gastrointestinal care
Hazardous drug safety
Hernia repair and fixation
Home care
Infection prevention
Infusion therapy
Interventional specialties
Lab automation
Medication and supply management
Microbiology solutions
Molecular diagnostics
Patient monitoring and temperature management
Prostate health
Sharps disposal solutions
Software solutions
Specimen collection
Syringes and needles
Urology and kidney health
Vascular access
Vascular surgery
Wound care

Product Line:

Please select subject first
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representative will get in touch with you shortly.
Ordering
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Onsite Visiting
Location Icon
850 W Rio Salado Pkwy, Tempe, AZ 85281 United States
Customer Service
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
6:00 a.m. – 4:30 p.m. Arizona Time (Monday-Friday)
Fax Icon
1.800.440.5376

Crosser iQ™ Ultrasonic CTO Device

Contact Us
Crosser_iQ_Ultrasonic_CTO_Device.jpg
Loading
Overview

The Crosser iQ™ CTO Recanalization System is made up of 3 main components:

The BD Recanalization System (Console and Footswitch) includes a non-sterile, reusable Console with an integrated roller pump, user interface and a Footswitch.

The Crosser iQ™ Ultrasonic CTO Device is connected to the BD Recanalization System Console via the power cord, through which power is converted into high-frequency ultrasonic mechanical vibrations to the tip of the device.

  • Designed to help cross peripheral arterial CTOs intraluminally
  • Automatically and selectively ablates plaque, while remaining atraumatic to elastic tissue
  • Simple, "plug-and-play" system
true

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Guidewire Port

Radiopaque Marker Band

"Support Taper" Transmission Wire

Hydrophilic Coated

GeoAlign Marking System

Irrigation Outlets

1.1mm Titanium Tip

Features and Benefits

Crosser iQTM 

Ultrasonic CTO Device
  • 5F sheath compatible, over-the-wire
  • 0.014" guidewire compatible
  • 146 cm working length
  • Handle activation, optional Footswitch
  • Recon™ Support Catheter is designed to guide and provide support for the Crosser iQ™ Ultrasonic CTO Device

 

Learn more about Recon™ Support Catheter

BD Recanalization System

Console and Footswitch
  • Simple, “plug-and-play” system
  • LCD screen with informative prompts
  • Integrated roller pump
  • Average setup time <2-minutes1

CTOs are Unpredicatable, Crossing Them Shouldn't Be

The Crosser iQ™ CTO Recanalization System automatically adjusts its power output to help stabilize the distal tip of the catheter to assist in crossing CTOs.

Crosser_iQ_3_images.jpg
Products & Accessories
Sort by:

Crossing Reimagined

Crosser iQ™ Ultrasonic CTO Device Warranty Program

BD’s next generation CTO crossing device, the Crosser iQ™ Ultrasonic CTO Device - a smart approach to crossing peripheral CTOs.

BD is proud to offer the Crosser iQ™ Ultrasonic CTO Device Warranty - if you treat a patient with Crosser iQ™ Ultrasonic CTO Device, per the IFU, and are unsuccessful in crossing the peripheral CTO intraluminally, then a no-charge replacement code will be sent to your account.

Contact your local BD representative for more details.

 

 

Program Overview

Program :  Through December 31, 2022*

 

Duration : 12 months from Program contract signing**

 

Criteria : Patient who receives treatment with Crosser iQ™ Ultrasonic CTO Device per the IFU, during this contract period, and the device did not successfully cross through the peripheral chronic total occlusion intraluminally

 

Warranty : No charge replacement of Crosser iQ™ Ultrasonic CTO Device code sent to account

 

 

 

ADAPT    

87% crossing success rate observed
in 8 cm synthetic lesion model1
 

 

ANCHOR

Designed to intraluminally cross unfavorable cap morphologies

95% CTO cap engagement observed in
simulated convex cap model2
 

 

 ACCELERATE

1 minute 29 seconds average activation time observed in 8 cm synthetic lesion model1

Footnotes

*BD reserves the right to terminate the Program at any time.

**Please note, signed Crosser iQ™ Ultrasonic CTO Device Purchase Agreement terms and conditions apply.

26/30 devices successfully crossed an 8 cm synthetic lesion model made of 10 mm of formula 8 on each end (replicating calcified end caps (no specified cap shape)) and 60 mm of formula 4 (replicating the fibrous middle of a CTO). Crossing success was defined as passing through the entire simulated lesion within 5 minutes or less of device activation. Device activation time ranged from 12 to 290 seconds. Device activation time was measured from the time of device engagement of the simulated lesion until the device crossed through the distal cap of the simulated lesion or until the device life expired and device activation stopped.

238/40 devices engaged an Ultracal30 gypsum convex cap stone successfully. Engagement success was defined as ability of the device to engage the simulated cap within 30 seconds of device activation.

Bench data on file, BD, Tempe, AZ. Bench data may not necessarily correlate to clinical performance. Different test methods may yield different results. Actual user experience may vary.

The BD Recanalization System (Console and Footswitch) and the Crosser iQ™ Ultrasonic CTO Device are indicated to facilitate the intra-luminal placement of conventional guidewires beyond peripheral artery chronic total occlusions. The Crosser iQ™ Ultrasonic CTO Device is contraindicated for use in the carotid arteries.

Potential Adverse Events: Bleeding which may require transfusion or surgical intervention· Puncture site hematoma, pain and tenderness · Hemorrhage · Embolism · Vessel perforation/dissection · Guidewire entrapment and/or fracture · Hypertension/Hypotension · Infection or fever · Allergic reaction · Pseudoaneurysm or fistula Aneurysm · Acute reclosure · Thrombosis · Ischemic events · Distal embolization · Excessive contrast load resulting in renal insufficiency or failure · Excessive exposure to radiation · Stroke/CVA · Restenosis · Repeat catheterization/angioplasty · Peripheral artery bypass · Amputation · Death · Other bleeding complications at access site.

EIFUs
Resources

Reference

1 Average set up time of less than 2 minutes is based upon BD internal testing involving four different surgical technicians who set up the BD Recanalization System through step 18 of the Crosser iQ™ Ultrasonic CTO Device instructions for use. Data on file, BD, Tempe, AZ. Bench data may not necessarily correlate to clinical performance. Different test methods may yield different results. Actual user experiences may vary.

 

Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.

BD-29469

true
Crosser iQ™ Ultrasonic CTO Device BD Crosser iQ™ Ultrasonic CTO Device

Crosser iQTM 

Ultrasonic CTO Device
,
  • 5F sheath compatible, over-the-wire
  • 0.014" guidewire compatible
  • 146 cm working length
  • Handle activation, optional Footswitch
  • Recon™ Support Catheter is designed to guide and provide support for the Crosser iQ™ Ultrasonic CTO Device

 

Learn more about Recon™ Support Catheter

,

BD Recanalization System

Console and Footswitch
,
  • Simple, “plug-and-play” system
  • LCD screen with informative prompts
  • Integrated roller pump
  • Average setup time <2-minutes1
/content/dam/bd-assets/bd-com/en-us/logos/bd/header-bd-logo.svg
CTO, PAD, Peripheral Arterial Disease, leg pain, swollen leg, occlusion, recanalization catheter